Revize Micro 0.04% Gel is a derivative of vitamin A utilized to address acne, characterized by blemishes or pimples on the facial area, chest, or back. In addition to combating acne, it aids in refining rough skin texture and minimizing the appearance of fine lines. This gel works by decreasing the overproduction of oil in the skin. For optimal results, it is advisable to apply it precisely at night, adhering to the duration and dosage established by your healthcare provider. The specific amount required and the treatment duration will be determined by your health condition. Prior to application, ensure the affected area is clean and dry, and then apply a thin layer of the gel as directed by your doctor. Avoid using this gel on areas of damaged or broken skin, and take care to prevent contact with the mouth, eyes, and nose. Noticeable improvements may take several weeks to manifest, so continued use is essential to maximize benefits. Should you not observe any progress after a few weeks, it is important to consult your doctor for further guidance. Overusing the gel or applying it more frequently than prescribed will not accelerate the effects and may lead to heightened side effects. Typical side effects may include skin irritation, dryness, and redness, which are generally mild and tend to resolve as your skin adjusts to the medication. To mitigate dryness in your mouth, lips, and eyes, it is recommended to stay hydrated and use a moisturizer. If these side effects are bothersome or persist, inform your healthcare provider. Serious adverse effects are uncommon. Additionally, this gel can heighten sensitivity to sunlight, thus limiting sun exposure is advisable. Avoid hair removal or laser treatments while undergoing this therapy. Use during pregnancy is discouraged due to the potential for birth defects, and consultation with a healthcare provider is crucial.
-15%

REVIZE MICRO 0.04% (Tretinoin (0.04% w/w))
Original price was: ₹253.40.₹216.20Current price is: ₹216.20.
Add to cart
Buy Now
Reviews
There are no reviews yet.